SCHEMBL6721798

SCHEMBL6721798

CC=C(C)CCC(=O)O

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6936921 1.00
Hydrochloric Acid SCHEMBL10640359 0.97 LMNA (0.52)
Hydrochloric Acid SCHEMBL10640365 0.97 LMNA (0.52)
SCHEMBL15418758 0.86 FNTA (0.55)
SCHEMBL22555394 0.86 FNTA (0.55)
SCHEMBL22555391 0.86 FNTA (0.55)
SCHEMBL22555392 0.86 FNTA (0.55)
SCHEMBL10933565 0.80 KMT2A (0.33)
SCHEMBL10933567 0.80 KMT2A (0.33)
SCHEMBL5182686 0.79

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 60 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-122059886-A Small molecule, preparation method, medicine and application 首都医科大学宣武医院 2026-05-19 CN claimed
CN-122059886-A Small molecule, preparation method, medicine and application 首都医科大学宣武医院 2026-05-19 CN disclosed
EP-4724066-A1 INOSINE MONOPHOSPHATE DEHYDROGENASE (IMPDH) INHIBITORS FOR THE TREATMENT AND PREVENTION OF BRAIN METASTASIS OF A CANCER McMaster University (CA) 2026-04-15 EP disclosed
WO-2025121408-A1 PERFUME COMPOSITION 高砂香料工業株式会社 2025-06-12 WO disclosed
US-12268694-B2 Combination pharmaceutical agents as RSV inhibitors ENANTA PHARMACEUTICALS, INC. (US) 2025-04-08 US disclosed
EP-4479366-A2 COMPOSITIONS AND METHODS RELATING TO ATP/P2X7R SIGNALING INHIBITION The Children's Medical Center Corporation (US) 2024-12-25 EP disclosed
WO-2024250116-A1 INOSINE MONOPHOSPHATE DEHYDROGENASE (IMPDH) INHIBITORS FOR THE TREATMENT AND PREVENTION OF BRAIN METASTASIS OF A CANCER MCMASTER UNIVERSITY (CA) 2024-12-12 WO disclosed
CN-118510520-A Pharmaceutical composition of mycophenolic acid and/or betamethasone for the treatment of ocular diseases 瑟菲斯眼科股份有限公司 2024-08-16 CN disclosed
WO-2023158601-A2 COMPOSITIONS AND METHODS RELATING TO ATP/P2X7R SIGNALING INHIBITION THE CHILDREN'S MEDICAL CENTER CORPORATION (US) 2023-08-24 WO disclosed
US-20220363640-A1 ANTIVIRAL COMPOUNDS Janssen Biopharma, Inc. (US) 2022-11-17 US disclosed
EP-0835248-A1 1-AMINO-3-BENZYLURACILS BASF AKTIENGESELLSCHAFT (DE) 1998-04-15 EP disclosed
WO-1997035845-A1 SUBSTITUTED 1-METHYL-3-BENZYLURACILS BASF AKTIENGESELLSCHAFT (DE) 1997-10-02 WO disclosed
CN-1143366-A 4-mycophenolic acid-amino derivatives SYNTEX INC (US) 1997-02-19 CN disclosed
CN-1141632-A 4-amino 6-substituted mycophenolic acid with immunosuppressive activity and derivatives thereof SYNTEX INC (US) 1997-01-29 CN disclosed
CN-1141040-A 6-substituted mycophenolic and derivatives with immunosuppressive activity SYNTEX INC (US) 1997-01-22 CN disclosed
WO-1997001543-A1 1-AMINO-3-BENZYLURACILS BASF AKTIENGESELLSCHAFT (DE) 1997-01-16 WO disclosed
EP-0745071-A1 4-AMINO 6-SUBSTITUTED MYCOPHENOLIC ACID AND DERIVATIVES WITH IMMUNOSUPPRESSIVE ACTIVITY SYNTEX (U.S.A.) INC. (US) 1996-12-04 EP disclosed
EP-0712403-A1 MATRIX METALLOPROTEASE INHIBITORS SYNTEX INC (US) 1996-05-22 EP disclosed
WO-1995004735-A1 MATRIX METALLOPROTEASE INHIBITORS SYNTEX (U.S.A.) INC. (US) 1995-02-16 WO disclosed
EP-0578388-A2 Fermentation process for preparing 10-hydroxy-C18-carboxylic acid and gamma-dodecalactone derivatives INTERNATIONAL FLAVORS &amp; FRAGRANCES INC. (US) 1994-01-12 EP disclosed